Author
Patrick Aebischer
- Indexed works
- 10
- Total citations
- 2,593
- Active years
- 8
Collaborators
Works in the record
Nature Medicine 2016
Preprint · OA
Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents
Neurobiology of Disease 2009
Preprint · CC-BY
Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
Cell Reports Medicine 2022
Open access · CC-BY
Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults
JAMA Network Open 2022
Open access · CC-BY
Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults
Journal of Clinical Investigation 2008
Open access · OA
Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease
Human Molecular Genetics 2008
Open access · CC0
Phosphorylation Does Not Prompt, Nor Prevent, the Formation of -synuclein Toxic Species in a Rat Model of Parkinson's Disease
European Journal of Clinical Nutrition 2021
Open access · CC-BY
Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population
Biomolecules 2015
Open access · CC-BY
Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease
Innovation in Aging 2017
Open access · OA
ORALLY ADMINISTERED UROLITHIN A IS SAFE AND MODULATES MUSCLE AND MITOCHONDRIAL BIOMARKERS IN ELDERLY
Innovation in Aging 2018
Open access · OA